The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma

Clinical Endocrinology

Volumn 47, Issue 6, 1997, Pages 713-720

  Pelikan, D M V ^a   Lion, H L ^a   Hermans, J ^a   Goslings, B M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID CARCINOMA; TREATMENT OUTCOME;

EID: 0031440829     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.3281154.x     Document Type: Article

References (28)

1. Beierwaltes, W.H., Nishiyama, R.H., Thompson, N.W., Copp, J.E. & Kubo, A. (1982) Survival time and cure in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. Journal of Nuclear Medicine, 23, 561-568.
2. Brown, A.P., Greening, W.P., McCready, V.R., Shaw, H.J. & Harmer, C.L. (1984) Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. British Journal of Radiology, 57, 323-327.
3. Casara, D., Rubello, D., Saladini, G., Masarotto, G., Favero, A., Girelli, M. & Busnardo, B. (1993) Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. Journal of Nuclear Medicine, 34, 1626-1631.
4. Dewan, S.S., Sharma, S.M. & Ganatra, R.D. (1979) Radioiodine in treatment of metastatic thyroid cancer. International Journal of Nuclear Medicine and Biology, 6, 213-214.
5. Emrich, D. & Creutzig, H. (1988) Benefits and risks of radioactive iodine therapy in differentiated thyroid carcinoma. Progress in Surgery, 19, 133-146.
6. Glanzmann, C. & Horst, W. (1979) Therapie des metastasierenden Schilddrüsen karzinoms mit 131-Jod. Strahlentherapie, 155, 223-229.
7. Glanzmann, C. & Lütolf, U.M. (1992) Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment. Strahlen-therapie und Onkologie, 168, 260-269.
8. Goslings, B.M. & Hannon, R. (1973) The effect of low-iodine diet on 131-1 therapy in follicular thyroid carcinoma. Netherlands Journal of Medicine, 16, 136-137.
9. Goslings, B.M. & Vielvoye, G.J. (1996) Embolization in combination with I-131 therapy in spinal metastases of follicular thyroid carcinoma (abstract no. 64). Journal of Endocrinological Investigation, 19(Suppl. to no. 6), 32.
10. Harmer, H.M. (1978) TNM classification of malignant tumours. Union Internationale Centre le Cancer, Geneva.
11. Marcocci, C., Pacini, F., Elisei, R., Schipani, E., Ceccaralli, C., Miccoli, P., Arganini, M. & Pinchera, A. (1989) Clinical and biological behavior of bone metastases from differentiated thyroid carcinoma. Surgery 106, 960-969.
12. Maxon, H.R. (1993) The role of I-131 in the diagnosis and treatment of thyroid cancer. Thyroid Today, 16, 1-9.
13. Maxon, H.R., Englaro, E.E., Thomas, S.R., Hertzberg, V.S., Hinnefeld, J.D., Chen, L.S., Smith, H., Cummings, D. & Aden, M.D. (1992) Radioiodine-131 therapy for well differentiated thyroid cancer - a quantitative radiation dosimetric approach: outcome and validation in 85 patients. Journal of Nuclear Medicine, 33, 1132-1136.
14. Maxon, H.R. & Smith, H.S. (1990) Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinology and Metabolism Clinics of North America, 19, 685-717.
15. Mazzaferri, E.L. & Jhiang, S.M. (1994) long-term impact of surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418-428.
16. McConahey, W.M., Hay, I.D., Woolner, L.B., Van Heerden, J.A. & Taylor, W.F. (1986) Papillary thyroid cancer treated at Mayo Clinic 1946 through 1970: initial manifestations, pathological findings, therapy, and outcome. Mayo Clinic Proceedings, 61, 978-996.
17. Nemec, J., Zamrazil, V., Pohunkova, D. & Röhling, S. (1979) Radioiodine treatment of pulmonary metastases of differentiated thyroid cancer: results and prognostic factors. Nuclear Medizin, 18, 86-90.
18. Pacini, F., Cetani, F., Miccoli, P., Mancusi, F., Ceccaralli, C., Lippi, F., Martino, E. & Pinchera, A. (1994) Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World Journal of Surgery, 18, 600-604.
19. Proye, C.A.G., Dromer, D.H.R., Carnaille, B.M., Gontier, A.J.P., Goropoulos, A., Carpentier, P., Lefebvre, J., Decoulx, M., Wemeau, J.L., Fossati, P. & Sulman, C. (1992) Is it still worthwhile to treat metastases from differentiated thyroid carcinoma with radioactive iodine. World Journal of Surgery, 16, 640-646.
20. Ruegemer, J.J., Hay, I.D., Bergstralh, E.J., Ryan, J.J., Offord, K.P. & Gorman, C.A. (1988) Distant metastases in differentiated thyroid carcinoma: a multivariate analysis. Journal of Clinical Endocrinology and Metabolism, 67, 501-508.
21. Samaan, N.A., Maheshwari, Y.K., Nader, S., Hill, C.S., Schultz, P.N., Haynie, T.P., Hickey, R.C., Clark, R.L., Goepfert, H., Ibanez, M.L. & Litton, C.E. (1983) Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. Journal of Clinical Endocrinology and Metabolism, 56, 1131-1138.
22. Samaan, N.A., Schultz, P.N., Hickey, R.C., Goepfert, H., Haynie, T.P., Johnston, D.A. & Ordonez, N.G. (1992) The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. Journal of Clinical Endocrinology and Metabolism, 75, 714-720.
23. Schelfhout, L.J.D.M., Creutzberg, C.L., Hamming, J.F., Fleuren, G.J., Smeenk, D., Van Hermans, J., de Velde, J.H. & Goslings, B.M. (1988) Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. European Journal of Clinical Oncology, 63, 960-967.
24. Schlumberger, M., Challeton, C., De Vathaire, F., Travagli, J.P., Gardet, P., Lumbroso, J.D., Francese, C., Fontaine, F., Ricard, M. & Parmentier, C. (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. Journal of Nuclear Medicine, 37, 598-605.
25. Schlumberger, M., Tubiana, M., De Vathaire, F., Hill, C., Gardet, P., Travagli, J.P., Fragu, P., Lumbroso, J., Caillou, B. & Parmentier, C. (1986) Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 63, 960-967.
26. Schober, O., Günter, H.-H., Schwarzrock, R. & Hundeshagen, H. (1986) Hämatologische Langzeitveränderungen bei der Radiojodtherapie des Schilddrüsenkarzinoms. Strahlentherapie und Onkologie, 163, 464-474.
27. Simpson, W.J., Panzarella, T., Carruthers, J.S., Gospodarowicz, M.K. & Sutcliff, S.B. (1988) Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. International Journal of Radiational Oncology, Biology and Physics, 14, 1063-1075.
28. Vickery, A.L., Wang, C.-A. & Walker, A.M. (1987) Treatment of intrathyroidal carcinoma of the thyroid. Cancer, 60, 2587-2595.